Assessing the Trends of Tramadol Utilization in the Medicare Part D Population in Rhode Island
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tramadol prescriptions decreased in Rhode Island
Area Of Science
- Pain Management
- Pharmacovigilance
- Public Health
Background
- Tramadol is an opioid analgesic.
- Opioid prescribing trends are a significant public health concern.
- Medicare Part D provides prescription drug coverage for beneficiaries.
Purpose Of The Study
- To evaluate tramadol dispensing patterns.
- To analyze trends among Medicare Part D beneficiaries in Rhode Island.
- To assess changes after tramadol's controlled substance scheduling.
Main Methods
- Analysis of Medicare Part D Provider Utilization and Payment Data (2013-2021).
- Statistical analysis of annual changes in tramadol dispensing proportions.
- Chi-squared tests for significance.
Main Results
- Tramadol prescriptions and patient numbers declined annually from 2014 to 2021.
- Prescriptions decreased from 42,157 to 33,026.
- Patients decreased from 12,654 to 9,653.
- The proportion of opioid prescriptions that were tramadol increased from 16.32% to 21.19% between 2013 and 2020.
Conclusions
- Tramadol utilization is decreasing in Rhode Island's Medicare Part D population.
- Tramadol represents an increasing share of total opioid dispensings.
- Further research is warranted on adverse outcomes associated with tramadol use.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...